Safety of conversion from cyclosporine sandimmune to cyclosporine neoral in stable liver transplant patients

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 1852-1853

  Baruch, Y ^a,b   Assy, N ^a   Kramsky, R ^a   Enat, R ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG ABSORPTION; DRUG FORMULATION; DRUG SAFETY; FEMALE; GRAFT REJECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; BLOOD PRESSURE; CREATININE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0031713636     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00455-2     Document Type: Conference Paper

References (10)

1. Vondersher J, Meizner A: Transplant Proc 26:2925, 1994
2. Holt DW, Mueller EA, Kovarik JM, et al: Transplant Proc 26:2935, 1994
3. Mueller EA, Kovarik JM, van Bree JB, et al: Pharm Res 11:301, 1994
4. Atkinson PR, Grant DR, Williams SE, et al: Transplant Proc 26:2953, 1994
5. Farber L, Maibucher A, Gressler F, et al: Transplant Proc 26:2988, 1994
6. Trull AK, Tan KKC, Uttridge J, et al: Lancet 341:433, 1993
7. Levy GA, Rasmussen A, Mayer AD, et al: Liver Transplant Surg 3:571, 1997
8. Munk IDM, Nagle A, Kelly DA: Hepatology 26 (suppl): 236A, 1997, (Abstract 432)
9. Donovan JP, Sorrell MF, Langnas AN, et al: Hepatology 26 (suppl): 237A, 1997 (Abstract 434)
10. Senel FM, Yildirim S, Karakayali H, et al: Transplant Int 10:357, 1997